Concepedia

Linxiaoxi Ma

LM

4

Publications

142

Citations

4

H-Index

2017

Active since

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Linxiaoxi Ma is an author at Fudan University Shanghai Cancer Center specializing in cancer therapeutics, breast cancer, and medicine.

Top concepts

Publications per year

2017–2024

4

Publications

4

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 55 citations

, , +5

Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients

Liang Guo, Yayun Chi, Jingyan Xue et al. · Scientific Reports · 2017 · 40 citations · Full text

Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer

Liang Guo, Chunmei Cao, Shyamal Goswami et al. · Clinical Science · 2020 · 34 citations · Full text

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study

Min He, Shuang Hao, Linxiaoxi Ma et al. · EClinicalMedicine · 2024 · 13 citations · Full text

Rows per page

1–4 of 4